Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02877732 · ClinicalTrials.gov registry record · NA
EYE-TRAC Advance: Technology Verification (ETA-TV) Cohort 2
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT02877732: Clinical Trial NA study, sponsored by Stanford University.
NCT02877732 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02877732, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
This is a prospective multi-center cohort feasibility and exploratory study.
Primary Outcome
The EYE-SYNC test will be performed immediately after an impact, 2 days, 7 days and 14 days post impact. The movement of eye will be tracked using EYE-SYNC. The data will be recorded in a surface tablet connected to EYE-SYNC.
Interventions
- DEVICE EYE-SYNC eye-tracking
- OTHER SCAT-3 subtests
- OTHER DEM
- OTHER Simple Reaction Time subtest of ANAM-SRT
- OTHER Level of Alertnesss
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2016-07 |
| Est. Completion | 2017-04 |
| Phase | NA |
Why NCT02877732 stopped before completion
NCT02877732 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which EYE-SYNC eye-tracking is the first listed.
NCT02877732 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02877732 about?
NCT02877732 is a clinical study titled "EYE-TRAC Advance: Technology Verification (ETA-TV) Cohort 2". This is a prospective multi-center cohort feasibility and exploratory study.
What is the current status of trial NCT02877732?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2016-07. Estimated completion is 2017-04.
What interventions are being tested in trial NCT02877732?
The interventions under investigation include: EYE-SYNC eye-tracking (DEVICE), SCAT-3 subtests (OTHER), DEM (OTHER), Simple Reaction Time subtest of ANAM-SRT (OTHER), Level of Alertnesss (OTHER).
Who is sponsoring clinical trial NCT02877732?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02877732's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia